These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 33405993)

  • 21. Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Novel CRTH2 Antagonist BI 1021958 at Single Oral Doses in Healthy Men and Multiple Oral Doses in Men and Women With Well-Controlled Asthma.
    Fowler A; Koenen R; Hilbert J; Blatchford J; Kappeler D; Benediktus E; Wood C; Gupta A
    J Clin Pharmacol; 2017 Nov; 57(11):1444-1453. PubMed ID: 28609567
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety, Tolerability and Pharmacokinetics of Yimitasvir Phosphate Capsule, a Novel Oral Hepatitis C Virus NS5A Inhibitor, in Healthy Chinese Volunteers.
    Zhao N; Xie R; Zhao X; Zhao H; Jia B; Zhang Y; Luo L; Huang Z; Li J; Wang X; Yan H; He B; Xie H; Ren Q; Cui Y
    Clin Drug Investig; 2019 Jul; 39(7):671-681. PubMed ID: 31079356
    [TBL] [Abstract][Full Text] [Related]  

  • 23. First-In-Human Study on Pharmacokinetics, Safety, and Tolerability of Single and Multiple Escalating Doses of Hepenofovir, a Novel Hepatic Targeting Prodrug of Tenofovir in Healthy Chinese Subjects.
    Zhang H; Gao L; Lou J; Wu M; Chen H; Yang L; Liu J; Zhu X; Li X; Li C; Wang M; Liu C; Guo W; Wang Y; Gao Z; Han L; Wang D; Jin W; Ding Y
    Front Pharmacol; 2022; 13():873588. PubMed ID: 35662718
    [No Abstract]   [Full Text] [Related]  

  • 24. Safety, Pharmacokinetics, and Pharmacodynamics of the TLR4 Agonist GSK1795091 in Healthy Individuals: Results from a Randomized, Double-blind, Placebo-controlled, Ascending Dose Study.
    Hug BA; Matheny CJ; Burns O; Struemper H; Wang X; Washburn ML
    Clin Ther; 2020 Aug; 42(8):1519-1534.e33. PubMed ID: 32739049
    [TBL] [Abstract][Full Text] [Related]  

  • 25. First-in-Human, Double-Blind, Randomized, Placebo-Controlled Trial of TQ-F3083, a New Dipeptidyl Peptidase-4 Inhibitor, in Healthy Chinese Adults.
    Liu J; Zhu X; Zhang H; Wei H; Yang D; Xu Z; Huo D; Li X; Ding Y
    Front Pharmacol; 2021; 12():689523. PubMed ID: 34366847
    [No Abstract]   [Full Text] [Related]  

  • 26. Safety, tolerability, pharmacokinetics, and pharmacodynamics of oral JNJ-64794964, a TLR-7 agonist, in healthy adults.
    Gane E; Pastagia M; Schwertschlag U; De Creus A; Schwabe C; Vandenbossche J; Slaets L; Fevery B; Smyej I; Wu LS; Li R; Siddiqui S; Oey A; Musto C; Van Remoortere P
    Antivir Ther; 2021 May; 26(3-5):58-68. PubMed ID: 35485332
    [TBL] [Abstract][Full Text] [Related]  

  • 27. First-in-Human Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E6742, a Dual Antagonist of Toll-like Receptors 7 and 8, in Healthy Volunteers.
    Yamakawa N; Tago F; Nakai K; Kitahara Y; Ikari S; Hojo S; Hall N; Aluri J; Hussein Z; Gevorkyan H; Maruyama T; Ishizaka S; Yagi T
    Clin Pharmacol Drug Dev; 2023 Apr; 12(4):363-375. PubMed ID: 36219471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety, tolerability, pharmacokinetics, and pharmacodynamics of fimasartan following single and repeated oral administration in the fasted and fed states in healthy subjects.
    Chi YH; Lee H; Paik SH; Lee JH; Yoo BW; Kim JH; Tan HK; Kim SL
    Am J Cardiovasc Drugs; 2011 Oct; 11(5):335-46. PubMed ID: 21910510
    [TBL] [Abstract][Full Text] [Related]  

  • 29. First-in-Human Studies to Evaluate the Safety, Tolerability, and Pharmacokinetics of a Novel 5-HT
    Nirogi R; Bhyrapuneni G; Muddana NR; Goyal VK; Pandey SK; Mohammed AR; Ravula J; Jetta S; Palacharla VRC
    Clin Drug Investig; 2021 May; 41(5):469-482. PubMed ID: 33788154
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Single and multiple dose pharmacokinetics and safety of ZSP1273, an RNA polymerase PB2 protein inhibitor of the influenza A virus: a phase 1 double-blind study in healthy subjects.
    Hu Y; Li H; Wu M; Zhang H; Ding Y; Peng Y; Li X; Yu Z
    Expert Opin Investig Drugs; 2021 Nov; 30(11):1159-1167. PubMed ID: 34654349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral resiquimod in chronic HCV infection: safety and efficacy in 2 placebo-controlled, double-blind phase IIa studies.
    Pockros PJ; Guyader D; Patton H; Tong MJ; Wright T; McHutchison JG; Meng TC
    J Hepatol; 2007 Aug; 47(2):174-82. PubMed ID: 17532523
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ASP3652 in First-in-Human and Ascending Multiple Oral Dose Studies in Healthy Subjects.
    Takizawa M; Cerneus D; Michon I; Rijnders S; van der Heide D; Meijer J; Stoelzel M; Sato Y
    Adv Ther; 2020 Sep; 37(9):3878-3900. PubMed ID: 32681461
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vesatolimod, a Toll-like Receptor 7 Agonist, Induces Immune Activation in Virally Suppressed Adults Living With Human Immunodeficiency Virus-1.
    Riddler SA; Para M; Benson CA; Mills A; Ramgopal M; DeJesus E; Brinson C; Cyktor J; Jacobs J; Koontz D; Mellors JW; Laird GM; Wrin T; Patel H; Guo S; Wallin J; Boice J; Zhang L; Humeniuk R; Begley R; German P; Graham H; Geleziunas R; Brainard DM; SenGupta D
    Clin Infect Dis; 2021 Jun; 72(11):e815-e824. PubMed ID: 33043969
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tolerability, pharmacokinetics and concentration-dependent hemodynamic effects of oral CF101, an A3 adenosine receptor agonist, in healthy young men.
    van Troostenburg AR; Clark EV; Carey WD; Warrington SJ; Kerns WD; Cohn I; Silverman MH; Bar-Yehuda S; Fong KL; Fishman P
    Int J Clin Pharmacol Ther; 2004 Oct; 42(10):534-42. PubMed ID: 15516022
    [TBL] [Abstract][Full Text] [Related]  

  • 35. JNJ-56136379, an HBV Capsid Assembly Modulator, Is Well-Tolerated and Has Antiviral Activity in a Phase 1 Study of Patients With Chronic Infection.
    Zoulim F; Lenz O; Vandenbossche JJ; Talloen W; Verbinnen T; Moscalu I; Streinu-Cercel A; Bourgeois S; Buti M; Crespo J; Manuel Pascasio J; Sarrazin C; Vanwolleghem T; Shukla U; Fry J; Yogaratnam JZ
    Gastroenterology; 2020 Aug; 159(2):521-533.e9. PubMed ID: 32343960
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacodynamics, pharmacokinetics, safety, and tolerability of encenicline, a selective α7 nicotinic receptor partial agonist, in single ascending-dose and bioavailability studies.
    Barbier AJ; Hilhorst M; Van Vliet A; Snyder P; Palfreyman MG; Gawryl M; Dgetluck N; Massaro M; Tiessen R; Timmerman W; Hilt DC
    Clin Ther; 2015 Feb; 37(2):311-24. PubMed ID: 25438724
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety, Pharmacokinetics, and Pharmacodynamics of the Autotaxin Inhibitor GLPG1690 in Healthy Subjects: Phase 1 Randomized Trials.
    van der Aar E; Desrivot J; Dupont S; Heckmann B; Fieuw A; Stutvoet S; Fagard L; Van de Wal K; Helmer E
    J Clin Pharmacol; 2019 Oct; 59(10):1366-1378. PubMed ID: 31012984
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apixaban, an oral, direct factor Xa inhibitor: single dose safety, pharmacokinetics, pharmacodynamics and food effect in healthy subjects.
    Frost C; Wang J; Nepal S; Schuster A; Barrett YC; Mosqueda-Garcia R; Reeves RA; LaCreta F
    Br J Clin Pharmacol; 2013 Feb; 75(2):476-87. PubMed ID: 22759198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized, double blind, dose escalation, first time in human study to assess the safety, tolerability, pharmacokinetics, and antiviral activity of single doses of GSK2485852 in chronically infected hepatitis C subjects.
    Wilfret DA; Walker J; Voitenleitner C; Baptiste-Brown S; Lovern M; Kim J; Adkison K; Shotwell B; Mathis A; Moss L; Lee D; Yu L; Gan J; Spaltenstein A
    Clin Pharmacol Drug Dev; 2014 Nov; 3(6):439-48. PubMed ID: 27129119
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics, pharmacodynamics, and tolerability of the dipeptidyl peptidase IV inhibitor LC15-0444 in healthy Korean men: a dose-block-randomized, double-blind, placebo-controlled, ascending single-dose, Phase I study.
    Lim KS; Kim JR; Choi YJ; Shin KH; Kim KP; Hong JH; Cho JY; Shin HS; Yu KS; Shin SG; Kwon OH; Hwang DM; Kim JA; Jang IJ
    Clin Ther; 2008 Oct; 30(10):1817-30. PubMed ID: 19014837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.